Bell HK, Ormerod AD. Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors. Br J Dermatol 2009; 160:7258. Brouwers MC, Kho ME, Browman GP et al. AGREE II: advancing guideline ... General Medicine eJournal, 1 week ago
1 images for "zs associate"
The Young Mizo Association (YMA), the largest social organisation in Mizoram, is against abolition of Hlamzuih, one of the oldest Mizo traditional taboos associated with infant death, creating a wide ideological gap between the YMA and the Church.NetIndia123.com, 1 month ago
Saint Luke's Mid America Heart Institute cardiologist presents findings at American Heart Association Scientific Meeting, results simultaneously published in JAMA Kansas City, Mo (PRWEB) November 17, 2014 Mikhail N. Kosiborod, M.D., ...MySanAntonio, 1 week ago ZS PHARMA : Clinical Trial Indicates Promising Results for Potential New Treatment for Hyperkalemia 4 Traders, 1 week ago
More from: Pharmacy Choice, PRWeb...and 6 other sources
PUBLIC RELEASE DATE: 17-Nov-2014 Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than ...EurekAlert!, 1 week ago Zirconium Cyclosilicate Lowers High Potassium Levels Associated With Potentially Lethal Cardiac Arrhythmias MedIndia, 1 week ago
Partnership delivers agile, cost-effective sales and marketing business intelligence solutions for life sciences EVANSTON, Ill. and PALO ALTO, Calif., Sept. 16, 2014 /PRNewswire-iReach/ -- ZS Associates and Reltio today announced they have entered ...Scottrade, 2 months ago
ZS Pharma Announces Late Breaking Presentation of Phase 3 HARMONIZE (ZS004) Trial Results in Patients With Hyperkalemia at AHA Annual Meeting
Additional ZS003 Phase 3 Presentations Also Featured at American Heart Association (AHA) Annual Scientific Meeting COPPELL, Texas, Nov. 6, 2014 (GLOBE NEWSWIRE) -- ZS Pharma (Nasdaq:ZSPH), a biopharmaceutical company developing novel treatments ...BizWire Express, 2 weeks ago ZS Pharma reports results from Phase III study of ZS-9 in patients with hyperkalemia Pharmaceutical Business Review, 1 day ago OncoMed Offers Data from Demcizumab; Celgene Receives Positive CHMP Opinion For OTEZLA BioMedReports, 4 days ago ZS Pharma Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine Wall Street Business Network, 4 days ago
According to a study published in the Canadian Medical Association Journal (CMAJ), common antibiotic treatments like amoxicillin and amocicillin-clavulanic acid, can result in diarrhea and candidias, although harms may be underreported. ...Noodls, 6 days ago Diarrhea and candidiasis associated with common antibiotic amoxicillin EurekAlert!, 1 week ago
CHICAGO — Treatment with sodium zirconium cyclosilicate was associated with rapid and sustained reductions in serum potassium compared with placebo in patients with hyperkalemia. The phase 3, double blind, multicenter HARMONIZE trial included ...Orthopedics Today, 1 week ago
FierceMedicalDevices caught up with Pratap Khedkar, managing principal at ZS Associates, which provides sales and marketing consulting to 18 of the 20 top medical devices companies and many Big Pharma players. He spoke at length about the Sunshine ...FierceMedicalDevices, 1 week ago
The NFU is reminding the public of the risks associated with sky lanterns, and urging them to think twice about releasing them into the air. Over the New Year, the successful Love your Countryside campaign will highlight the issue of how dangerous ...NFU Online, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!